As one of the important dietary antioxidants, (-)-epicatechin is a potent reactive oxygen species (ROS) scavenger involved in the redox modulation of the cell. When scavenging ROS, (-)-epicatechin will donate two electrons and become (-)-epicatechin quinone, and thus take over part of the oxidative potential of the ROS. The aim of the study is to determine where this chemical reactivity resides in (-)-epicatechin quinone. When this reactivity is spread out over the entire molecule, i.e. over the AC-ring and B-ring, this will lead to partial epimerization of (-)-epicatechin quinone to (-)-catechin quinone. In our experiments, (-)-epicatechin quinone was generated with tyrosinase. The formation of (-)-epicatechin quinone was confirmed by trapping with GSH, and identification of (-)-epicatechin-GSH adducts. Moreover, (-)-epicatechin quinone could be detected using Q-TOF/MS despite its short half-life. To detect the epimerization, the ability of ascorbate to reduce the unstable flavonoid quinones into the corresponding stable flavonoids was used. The results showed that the reduction of the formed (-)-epicatechin quinone by ascorbate did not result in the formation of an appreciable amount of (-)-catechin. Therefore it can be concluded that the chemical reactivity of (-)-epicatechin quinone mainly resides in its B-ring. This could be corroborated by quantum chemical calculations. Understanding the stabilization of the (-)-epicatechin quinone will help to differentiate between flavonoids and to select the appropriate compound for a specific disorder.
of (-)-epicatechin quinone to (-)-catechin quinone. In the antioxidant network, the relatively unstable flavonoid quinones can be recycled by ascorbate to the corresponding stable flavonoids. Therefore oxidation of (-)-epicatechin, followed by the epimerization and the reduction of the (-)-epicatechin quinone by ascorbate, will lead to the formation of (-)-catechin out of (-)-epicatechin. We determined the extent of epimerization of (-)-epicatechin to (-)-catechin during this oxidation / reduction cycle. This helps to understand where the oxidative potential of (-)-epicatechin quinone resides within the molecule. Understanding the stabilization of the quinones will help us to differentiate between polyphenolics and to select the appropriate compound for a specific disorder. Moreover, the epimerization of (-)-epicatechin to (-)-catechin would be a tool to evaluate the antioxidant activity and recycling of (-)-epicatechin in biological systems.
Materials and methods

Chemicals
(-)-Epicatechin, (-)-catechin, tyrosinase, ascorbate and GSH were purchased from Sigma (St. Louis, MO, USA) and dissolved in assay buffer (100 mM ammonium bicarbonate, pH 7.4).
(-)-Epicatechin oxidation
The oxidation of 50 µM (-)-epicatechin was performed at 37°C in the assay buffer and started by adding 10 U/mL tyrosinase. After starting the oxidation, the UV absorption spectrum (λ = 200-600 nm) was recorded every 2 min for 10 min (see legend of Fig. 2 ). In parallel, 50 µM ascorbate or 100 µM GSH were added to (-)-epicatechin before starting the reaction [14, 20] . The ascorbate consumption was determined from the absorption at 270 nm using a molar extinction coefficient of 3640 M −1 •cm −1 . The reactions were first monitored spectrophotometrically for 5 min and then analyzed with HPLC and UHPLC-Q-TOF/MS.
HPLC analysis
High performance liquid chromatography (HPLC) coupled to ultraviolet detection at 230 nm was performed using an Agilent 1260 HPLC system and a diode array detector (Agilent Technologies, Santa Clara (CA), USA). An Apollo C18 column (150 × 4.60 mm i.d., 5 µm) was used. The mobile phase was composed of solvent A (H 2 O) and solvent B (acetonitrile). The gradient program was: 0-2 min: 96-92% A, 2-11 min: 92-75% A. After each injection, 90% of B was used to wash the column for 5 min, and the column was reequilibrated with 4% of B for 5 min. The flow rate was 1.0 mL/min and 20 µL of samples were injected [21, 22] .
UHPLC-ESI-Q-TOF/MS and MS/MS analysis
The reaction products were separated using an Agilent 1290 infinity ultrahigh performance liquid chromatography (UHPLC) system (Agilent Technologies, Santa Clara (CA), USA). The UHPLC was equipped with a quaternary pump with an integrated vacuum degasser (G4204A), an autosampler (G4226A) with a thermostat (G1330B), and a thermostatted column compartment (G1316C). An Agilent Extend C18 column (2.1 × 50 mm, 1.8 µm), with an Agilent Eclipse plus C18 guard column (2.1 × 5 mm, 1.8 µm), was selected as the stationary phase. The mobile phase consists of a mixture of 0.1% (v/v) formic acid in water (solvent A) and acetonitrile (solvent B).
The flow rate was set to 0.4 mL/min, and the column temperature was maintained at 25°C. The gradient elution started with 10% B, increased linearly to 35% B over 4 min, and continued to increase to 75% solvent B over 4.75 min before decreasing to 10% B over 5.50 min. An equilibrium period of 1.25 min was used between two injections. The injection volume was 10 µL.
(-)-Epicatechin metabolites were detected using an Agilent 6550 iFunnel Accurate-Mass Quadrupole Time-of-Flight Mass Spectrometer (Q-TOF/MS) equipped with Dual Agilent Jet Stream technology for electrospray ionization (ESI) interface in the negative ionization mode. The capillary voltage was set to 2500 V. The temperature and flow rate of the drying gas were set to 150°C and 20 L/min, respectively, while the temperature and flow rate of the sheath gas were 350°C and 12 L/ min, respectively. The nebulizer pressure was controlled to 25 psi. The mass range for the TOF scanning was set to 50-1700 m/z. Peaks of eluents corresponding to (-)-epicatechin and (-)-epicatechin metabolites were subjected to Q-TOF MS/MS analysis to achieve a high mass accuracy. The collision energies were fixed to 35 and 32 for (-)-catechin and (-)-epicatechin, respectively. The m/z range for the targeted MS/MS acquisition was set to 50-1700 m/z in negative ESI mode. The mass accuracy was constantly checked via online calibration using a calibration solution containing the internal reference ions at m/ z at 112.9855 and 1033.9881in negative ionization mode. Data were analyzed and processed using Agilent Mass Hunter Workstation Quantitative and Qualitative Analysis software B.06.01. Structure confirmation of epicatechin metabolites was obtained by Agilent Mass Hunter structure correlator software [23, 24] .
LUMO map of (-)-epicatechin quinone
Quantum molecular calculations were performed using Spartan '16 to analyze the tautomers of the oxidized (-)-epicatechin. The Lowest Unoccupied Molecular Orbital (LUMO) energies (kJ/mol) of the tautomers of (-)-epicatechin quinone were calculated as well as their equilibrium geometry under Hartree-Fock (HF) 6-31G* basis set. The dihedral angles between the plane of the AC-ring and that of the B-ring of (-)-epicatechin quinones were also determined [17, 25] .
Statistics
All experiments were performed at least in triplicate. Results are shown as mean ± standard error of the mean (S.E.M.) or as a typical example.
Results
(-)-Epicatechin is oxidized by tyrosinse into (-)-epicatechin quinone
Addition of tyrosinase to (-)-epicatechin resulted in the oxidation of (-)-epicatechin, which was evident from the change in the UV spectrum ( Fig. 2A) . HPLC analysis of the incubation mixture confirmed that (-)-epicatechin was consumed during the oxidation process (Fig. 3B) . The Q-TOF MS/MS analysis showed that (-)-epicatechin quinone was formed ( (Fig. 4A ). The diastereoisomers, (-)-epicatechin and (-)-catechin, gave almost the same fragment ions indicating that the isomers could not be distinguished by only using their mass spectra. Using HPLC analysis, (-)-epicatechin and (-)-catechin showed a relatively large difference in the retention time, which were 10.6 min and 9.1 min respectively (Fig. 3) . This was used to selectively detect both diastereoisomers.
The confirmation of the formation of (-)-epicatechin quinone
When (-)-epicatechin is oxidized by tyrosinase in the presence of GSH, the change in the UV spectrum indicated that (-)-epicatechin-GSH adducts were formed (Fig. 2B ). HPLC analysis shows new peaks in the chromatogram at 2.9 and 3.4 min (Fig. 3C ) also indicating the formation of GSH adducts. Q-TOF/MS analysis of (-)-epicatechin interacting with tyrosinase and GSH confirms the presence of (-)-epicatechin-GSH adducts, based on the characteristic fragment ions of (-)-epicatechin-GSH of 594.14 m/z, 272.09 m/z, 143.05 m/z and 321.04 m/z (Fig. 4C) . Matching the observed MS/MS fragments with the proposed structure provides additional evidence for the formation of (-)-epicatechin-GSH adducts (Fig. 5) . The formation of (-)-epicatechin-GSH adducts confirms that tyrosinase converts (-)-epicatechin into its quinone. It is concluded that (-)-epicatechin is first converted into (-)-epicatechin quinone, and subsequently the quinone reacts with GSH into (-)-epicatechin-GSH adducts.
No epimerization of (-)-epicatechin quinone to (-)-catechin quinone
When (-)-epicatechin is oxidized by tyrosinase in the presence of ascorbate, the UV recordings indicate that there is no net consumption of (-)-epicatechin. However, the spectral change observed at 270 nm indicates that ascorbate is greatly consumed in the presence of (-)-epicatechin and tyrosinase (Fig. 2C) . The rate of ascorbate consumption with (-)-epicatechin and tyrosinase (2.22 ± 0.06 µM/min) is much higher than that of ascorbate with tyrosinase (0.60 ± 0.03 µM/ min) (Fig. 6 ). HPLC analysis confirmed that hardly any net oxidation of (-)-epicatechin by tyrosinase occurs in the presence of ascorbate (Fig. 3D) . These results indicate that in the incubation with ascorbate, (-)-epicatechin is first oxidized into (-)-epicatechin quinone and that the quinone immediately reacts with ascorbate to regenerate (-)-epicatechin. Assuming that ascorbate and (-)-epicatechin quinone react 1:1, the rate of (-)-epicatechin quinone formation equals to ascorbate consumption by tyrosinase, which is 1.63 ± 0.07 µM/min (Fig. 5) .
When (-)-epicatechin is oxidized by tyrosinase in the presence of ascorbate, (-)-epicatechin quinone is formed. This quinone might be stabilized by epimerization, with the tautomeric forms given in Fig. 1 . In the quinone intermediate, the C 2 -C 1 ' bound changes from a single bound to a double bound. Converting this double bound back to a single bound can be achieved in two manners and therefore this would lead to (partial) epimerization at the asymmetric C 2 carbon. This would result in (partial) conversion of (-)-epicatechin quinone into (-)-catechin quinone. Due to the limited stability of the quinone, this was not examined directly by examining the epimerization of the quinone itself.
In the presence of ascorbate, the quinone is not degraded but immediately reduced. If the epimerization of the quinone would take place, the reduction of the quinone by ascorbate would yield (-)-catechin as well as (-)-epicatechin. As described above, the epimerization of (-)-epicatechin to (-)-catechin can be examined using HPLC since they are diastereoisomers.
Fig. 4. Q-TOF MS/MS spectra of (-)-epicatechin (A), (-)-epicatechin quinone (B) and (-)-epicatechin-GSH adducts (C) with characteristic fragment ions.
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In the incubation of (-)-epicatechin with tyrosinase and ascorbate, no appreciable amount of (-)-catechin was detected using HPLC. This indicates that there is no substantial epimerization of (-)-epicatechin and (-)-catechin during oxidation. In Supplementary information, the LC/MS chromatograms obtained in conformation of the identity of the (-)-epicatechin quinone and (-)-epicatechin-GSH adducts, are shown. A trace of (-)-catechin was detected in the incubation of (-)-epicatechin with tyrosinase and ascorbate. A similar trace of (-)-catechin was detected in the (-)-epicatechin calibration standard and in the incubation of (-)-epicatechin without tyrosinase and ascorbate. That only traces of (-)-catechin were detected confirms the HPLC result that no substantial epimerization takes place.
The LUMO energy of (-)-epicatechin quinone
In the oxidative activity of (-)-epicatechin quinone, the LUMO accepts the electrons and is thus pivotal in its reactivity. In Fig. 7 , it is shown how the energy of the LUMO orbital is distributed over the molecule in the three tautomers of (-)-epicatechin quinone. With the energy of 136.04 kJ/mol, the LUMO of quinone intermediate is located in B-ring and for a small part also located in the C-ring. The LUMO of (-)-epicatechin quinone and (-)-catechin quinone are concentrated in Bring, and their energies are 44.38 kJ/mol and 36.66 kJ/mol respectively. The high energy difference between (-)-epicatechin quinone (44.38 kJ/mol) and the quinone intermediate (136.04 kJ/mol) indicates that the formation of quinone intermediate is not likely to occur. The calculations also show that there is a relatively large difference in the dihedral angle between the three tautomers of (-)-epicatechin quinone. The large difference in dihedral angle between (-)-epicatechin quinone and the quinone intermediate also indicates that there is no substantial isomerization. This further corroborates that the chemical reactivity of (-)-epicatechin quinone mainly resides in its B-ring.
Discussion
Many studies have proved that dietary antioxidants from food support the cellular defense system in dealing with oxidative stress [26] . (-)-Epicatechin, one of the most important dietary antioxidants, has gained significant attention because of its potent antioxidant activity [27] . It has been proved that the B-ring of (-)-epicatechin, a catechol moiety, is essential for its direct antioxidant activity to scavenge ROS [28] . When scavenging ROS, (-)-epicatechin will be oxidized into its two-electron oxidation product, (-)-epicatechin quinone. This quinone is much less reactive than the ROS scavenged, which is pivotal in the redox modulating effect of (-)-epicatechin [29] . Nevertheless, this quinone has taken over part of the reactivity of the ROS scavenged, and it can react e.g. with thiol groups. The research aim of the study is to unravel one aspect of (-)-epicatechin quinone, namely its stabilization.
Looking at its chemical structure, (-)-epicatechin quinone might be stabilized by the tautomerization as depicted in Fig. 1 .
In present study, (-)-epicatechin quinone was formed using tyrosinase. GSH is known to adduct quinones. The formation of (-)-epicatechin quinone was supported by the (-)-epicatechin-GSH adducts found when GSH was added to the incubation of (-)-epicatechin with tyrosinase. The formed (-)-epicatechin-GSH adducts were detected using UV, HPLC and Q-TOF /MS. Moreover, the formation of (-)-epicatechin quinone was also confirmed with Q-TOF /MS detection. To our knowledge this is the first time that (-)-epicatechin quinone was directly detected.
Quinones of polyphenols have a short half-life. Therefore, ascorbate was used to reduce the quinones formed during the tyrosinase catalyzed oxidation of (-)-epicatechin to the corresponding more stable polyphenols. If the tautomerization of the (-)-epicatechin quinone to the (-)-catechin quinone occurs (as depicted in Fig. 1) , the reduction by ascorbate will result not only in the recycling of (-)-epicatechin, but also in the formation of (-)-catechin.
That ascorbate indeed directly reduces the (-)-epicatechin quinone formed into (-)-epicatechin is shown by the UV and HPLC results of the incubation mixture containing (-)-epicatechin, tyrosinase and ascorbate. In this incubation system, ascorbate is consumed, while (-)-epicatechin is instantaneously recycled and therefore the concentration of (-)-epicatechin stays the same. The HPLC coupled with UV detection does not show the formation of a detectible amount of (-)-catechin. This indicates that no appreciable epimerization of (-)-epicatechin quinone to (-)-catechin quinone occurs.
The LC/MS chromatograms presented in Supplementary information shows that a trace of (-)-catechin was detected in the incubation mixture of (-)-epicatechin with tyrosianse and ascorbate. Similarly, a trace of (-)-catechin was also detected in the (-)-epicatechin calibration standard and in the incubation of (-)-epicatechin without tyrosinase and ascorbate. The later findings indicate that the trace amount of (-)-catechin found are formed by "spontaneous epimerization" of (-)-epicatechin.
In the epimerization of (-)-epicatechin quinone to (-)-catechin difference between the ascorbate consumption with and without (-)-epicatechin was ascribed to reduction of the (-)-epicatechin quinone generated by the tyrosinase catalyzed oxidation of (-)-epicatechin. This was used to estimate the rate of (-)-epicatechin quinone formation. Fig. 7 . The tautomers of (-)-epicatechin quinone, their Lowest Unoccupied Molecular Orbital (LUMO) map, and dihedral angle between the plane of the AC-ring and that of the B-ring. In depicting the dihedral angle, only C 2 and C 3 of the AC-ring are shown for sake of clarity. The large difference in the dihedral angle is indicative for the high energy barrier between the tautomers and can explain why the proposed tautomerization does not take place.
quinone, the relatively big difference in the dihedral angle (the angle between the plane of AC-ring and that of the B-ring) between (-)-epicatechin quinone and the quinone intermediate will cause an energy barrier that is hard to overcome. In the spontaneous epimerization of (-)-epicatechin (dihedral angle −57.03°) to (-)-catechin (dihedral angle −55.74°), the overall change in dihedral angle is similar to that of the corresponding quinones (from −55.96°to 55.55°, Fig. 7) . A difference is that the C-ring is opened in the intermediate of the spontaneous isomerization ( Fig. 8 ) and there is no fixed "dihedral angle" between the ring systems because the C-ring is not a ring anymore [30] . This makes the quinone intermediate of spontaneous isomerization much more flexible than the rigid quinone intermediate depicted in Fig. 1 . Therefore, the conformational change from (-)-epicatechin to the flexible intermediate is relatively small compared to the big conformational change from (-)-epicatechin quinone to the rigid quinone intermediate. This suggests that the spontaneous epimerization of (-)-epicatechin is quicker than the epimerization of (-)-epicatechin quinone. Actually, that only traces of (-)-catechin were detected confirms the HPLC data that no substantial epimerization takes place. The reactivity of (-)-epicatechin quinone, that is primarily due to its ability to easily accept electrons, was also evaluated by constructing its LUMO map. It shows that the LUMO energy of (-)-epicatechin quinone is indeed concentrated in the B-ring. Within the B-ring, the most electron deficient positions of (-)-epicatechin quinone are on the 2', 5' and 6' position. Consequently, nucleophiles such as GSH are expected to adduct to the B-ring at these positions. Previously, it has been reported that indeed these mono GSH adducts in B-ring are formed [31] . This further confirms that the chemical reactivity of (-)-epicatechin quinone primarily resides in B-ring.
When quercetin, another important polyphenol, is oxidized, it will also generate a quinone that can react with thiols. In contrast to (-)-epicatechin quinone, GSH will adduct to the 6 and 8 position of the A-ring of quercetin quinone. This indicates that the chemical reactivity of quercetin quinone does not reside only in B-ring but is spread out over the AC-ring as well as the B-ring, so over the entire molecule [14, 32] . With a high concentrated electron density in B-ring, (-)-epicatechin quinone is harder than quercetin quinone that has its electron density spread over the molecule. According to Pearson's Hard and Soft Acids and Bases concept, 'hard' electrophiles will more likely react with 'hard' nucleophiles and 'soft' electrophiles will more likely react with 'soft' nucleophiles [33] . It is obvious that such a difference in chemical reactivity between these bioactives will be reflected in a difference in their biological effects. However, this is still mainly a "terra incognita". The present study is a step further in the differentiation between bioactive polyphenols to finally come up with a rational selection for the appropriate compound for a specific disorder. We would like to stress that the difference between 'hard' and 'soft' redox modulating compounds should be acknowledged and further elaborated in clinical studies with polyphenols.
Conclusions
(-)-Epicatechin oxidation involves two electron oxidation of its Bring, giving (-)-epicatechin quinone. Our results show that there is no epimerization of (-)-epicatechin quinone and (-)-catechin quinone in the oxidation process. Therefore, it is concluded that the chemical reactivity of (-)-epicatechin quinone mainly resides in its B-ring.
